Mitoxantrone, vinorelbine and prednisone (MVD) in the treatment of metastatic hormonoresistant prostate cancer — a phase II trial
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Urology,Oncology
Link
http://www.nature.com/articles/4500685.pdf
Reference28 articles.
1. Parker SL, Tong T, Bolden S, Wingo PA . Cancer statistics. CA Cancer J Clin 1997; 47: 5–27.
2. Goktas S, Crawford ED . Optimal hormonal therapy for advanced prostatic carcinoma. Semin Oncol 1999; 26: 162–173.
3. Oh WK . Chemotherapy for patients with advanced prostate carcinoma. Cancer 2000; 88: 3015–3021.
4. Culine S, Droz J-P . Chemotherapy in advanced androgen-independent prostate cancer 1990–1999: A decade of progress? Ann Oncol 2000; 11: 1523–1530.
5. Eisenberger MA . Chemotherapy for prostate carcinoma. NCI Monogr 1988; 7: 151–163.
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Bioreductive activation of mitoxantrone by NADPH cytochrome P450 reductase does not change its apoptotic stimuli properties in regard to sensitive and multidrug resistant leukaemia HL60 cells;European Journal of Pharmacology;2013-12
2. “I bought this at eastern market”: Vending, value, and social relations in an urban street market;Economic Development, Integration, and Morality in Asia and the Americas;2009-01
3. Assessing outcomes in prostate cancer clinical trials;Cancer;2008-09-01
4. Finite Element Heterogeneous Multiscale Methods with Near Optimal Computational Complexity;Multiscale Modeling & Simulation;2008-01
5. Bioreductive activation of mitoxantrone by NADPH cytochrome P450 reductase. Implications for increasing its ability to inhibit the growth of sensitive and multidrug resistant leukaemia HL60 cells;Cancer Letters;2007-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3